Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 15/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 9/20 | 0.47 |
| ▸ | AR | P10275 | 8/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8541047 | 0.89 | PGR (0.48) | PGRNR3C1ARCYP3A4LMNA | |
| SCHEMBL8536181 | 0.88 | PGR (0.49) | PGRNR3C1ARCYP3A4LMNA | |
| SCHEMBL8536387 | 0.88 | PGR (0.51) | PGRNR3C1ARCYP3A4LMNA | |
| SCHEMBL8652179 | 0.86 | PGR (0.42) | PGRNR3C1ARCYP3A4 | |
| SCHEMBL8767943 | 0.85 | PGR (0.51) | PGRNR3C1ARCYP3A4NR3C2 | |
| SCHEMBL8767837 | 0.85 | PGR (0.50) | PGRNR3C1ARCYP3A4NR3C2 | |
| SCHEMBL8538113 | 0.84 | PGR (0.47) | PGRNR3C1ARCYP3A4LMNA | |
| SCHEMBL30107690 | 0.84 | PGR (0.66) | PGRNR3C1ARCYP3A4NR3C2 | |
| SCHEMBL8767831 | 0.84 | PGR (0.53) | PGRNR3C1ARCYP3A4NR3C2 | |
| SCHEMBL9019827 | 0.83 | NR3C1 (0.59) | PGRNR3C1ARCYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0567469-B1 | 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES | SCHERING AG (DE) | 1997-08-27 | — | — | EP | claimed |
| EP-0567469-B1 | 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES | SCHERING AG (DE) | 1997-08-27 | — | — | EP | disclosed |
| US-5426102-A | Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |